Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 965Urinary Bladder Neoplasms 268Carcinoma, Renal Cell 253Kidney Neoplasms 146Breast Neoplasms 131Carcinoma, Transitional Cell 127Neoplasms 122Colorectal Neoplasms 100Ovarian Neoplasms 93Melanoma 85Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 83Neoplasm Metastasis 79Pancreatic Neoplasms 69Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 59Stomach Neoplasms 56Head and Neck Neoplasms 52Endometrial Neoplasms 50Squamous Cell Carcinoma of Head and Neck 48Esophageal Neoplasms 44Adenocarcinoma 44Testicular Neoplasms 42Carcinoma, Hepatocellular 41Sarcoma 39Triple Negative Breast Neoplasms 34Liver Neoplasms 32Disease 31Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Interventions

tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Recurrence, Local × Genitourinary × Clear all
NCT06441110 2024-06-04

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Fujian Medical University Union Hospital

Phase 3 Recruiting
76 enrolled
Genitourinary

Urinary Bladder Neoplasms, Motor Activity, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡